Package 71610-031-60

Brand: divalproex sodium

Generic: divalproex sodium
NDC Package

Package Facts

Identity

Package NDC 71610-031-60
Digits Only 7161003160
Product NDC 71610-031
Product ID 71610-031_0f33ee94-fff3-4ae7-92fc-16f72a983d21
Description

90 TABLET, DELAYED RELEASE in 1 BOTTLE (71610-031-60)

Marketing

Marketing Status
Marketed Since 2018-01-19
Brand divalproex sodium
Generic divalproex sodium
Sample Package No

Linked Drug Pages (1)

Divalproex Sodium ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "0f33ee94-fff3-4ae7-92fc-16f72a983d21", "openfda": {"unii": ["644VL95AO6"], "rxcui": ["1099678"], "spl_set_id": ["b74adc5e-e92d-46a7-afdc-a6464a440bde"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, DELAYED RELEASE in 1 BOTTLE (71610-031-60)", "package_ndc": "71610-031-60", "marketing_start_date": "20180119"}], "brand_name": "Divalproex Sodium", "product_id": "71610-031_0f33ee94-fff3-4ae7-92fc-16f72a983d21", "dosage_form": "TABLET, DELAYED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "71610-031", "generic_name": "Divalproex Sodium", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Divalproex Sodium", "active_ingredients": [{"name": "DIVALPROEX SODIUM", "strength": "250 mg/1"}], "application_number": "ANDA078182", "marketing_category": "ANDA", "marketing_start_date": "20140321", "listing_expiration_date": "20261231"}